Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
13.74
+0.09 (0.66%)
At close: May 12, 2025, 4:00 PM
14.00
+0.26 (1.89%)
After-hours: May 12, 2025, 6:51 PM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $558.06 million as of May 12, 2025. Its market cap has decreased by -72.49% in one year.
Market Cap
558.06M
Enterprise Value
-144.07M
1-Year Change
-72.49%
Ranking
Category
Stock Price
$13.74
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $558.06M, an increase of 44.83%. That is a compound annual growth rate of 7.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 554.40M | -13.54% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 675.29B |
| Johnson & Johnson | 371.76B |
| UnitedHealth Group | 342.78B |
| AbbVie | 337.51B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 230.51B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |